Pfizer management said on Tuesday that they do not believe Lipitor sales will immediately plunge when generic versions of similar drugs hit pharmacy shelves later this year.
"To assume that they will fall off a cliff, that's not a realistic assessment," Pfizer Vice Chairman David Shedlarz told investors Tuesday at the annual Deutsche Bank health-care conference in Boston.
There's more.
"It won't be like a light switch, where you pull the switch down and all Lipitor sales go away. It'll be more like a shade," added Patrick Kelly, who heads up Pfizer's U.S. pharmaceuticals division.
Ok guys. You are now on the record.
No comments:
Post a Comment